🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to evaluate the progress free surviv...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-04-23
Trial ID
NCT04282980
Treatments Being Tested
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Status
Completed
Location
Honor Health (GIST, mastocytosis, other solid tumors)
Start Date
2015-11
Trial ID
NCT02571036
the primary objective of this study is to assess the efficacy (progression-...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-11-25
Trial ID
NCT04633122
Treatments Being Tested
This is an open-label, single-arm, multicenter expanded access study to pro...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04148092
Treatments Being Tested
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in...
Status
Recruiting
Location
University of Southern California - Norris Comprehensive Cancer Center
Start Date
2023-09-28
Trial ID
NCT05957367
Treatments Being Tested
This is a 2-arm, randomized, open-label, international, multicenter study c...
Status
Active Not Recruiting
Location
Mayo Clinic Scottsdale
Start Date
2019-02-08
Trial ID
NCT03673501
Treatments Being Tested
To evaluate the safety of DCC-2618 in patients with unresectable, metastati...
Status
Recruiting
Location
National Cancer Center Hospital East
Start Date
2026-07-07
Trial ID
NCT07618377
Treatments Being Tested
This is a 2-arm, randomized, placebo-controlled, double-blind, internationa...
Status
Completed
Location
HonorHealth
Start Date
2018-02-27
Trial ID
NCT03353753
Treatments Being Tested
This is a Phase 3, 2-arm, randomized, open-label, global, multicenter study...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2023-12-13
Trial ID
NCT05734105
Treatments Being Tested
Multicenter, open-label Phase 1b/2 study of ripretinib in combination with ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11
Trial ID
NCT05080621
Treatments Being Tested